D. E. Shaw & Co »

BioCryst Pharmaceuticals shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2013-03-31 $153k 129k 1.19
2012-12-31 $261k 184k 1.42
2012-06-30 $1.6M 398k 3.98
2011-06-30 $2.5M 661k 3.82
2010-12-31 $3.8M 736k 5.17

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon (AMZN)
Tesla Motors Put Option (TSLA)
Netflix Put Option (NFLX)
Booking Holdings Call Option (BKNG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Eli Lilly & Co. Call Option (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation (BAC)
Palantir Technologies Cl A (PLTR)
Citigroup Com New Put Option (C)

View all positions for D. E. Shaw & Co

Top funds holding BioCryst Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding BioCryst Pharmaceuticals